Doug Hampton PALO ALTO, Calif., May 30, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the following upcoming investor conferences: Jefferies Healthcare Conference, June 7, 2023, 1:30 PM ET (10:30 AM PT), New … Read more
DUBLIN, May 30, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2023 Goldman Sachs Global Healthcare Conference. Company management will participate in a fireside chat on Tuesday, June 13, 2023, at 3:20 p.m. PT / 11:20 p.m. IST. An audio webcast of the fireside chat will … Read more
PHILADELPHIA, May 30, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several healthcare industry conferences in June 2023. These conferences include: 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Yara Abdou, … Read more
TORONTO, May 30, 2023 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the second quarter ended March 31, 2022. Q2 2023 Financial Highlights Sales … Read more
MOSAIC Study is First to use MRI to Assess Inflammation in Peripheral Joints and Entheses in Psoriatic Arthritis Patients Exploratory Analysis Examines Effects of Otezla on Cardiometabolic Parameters THOUSAND OAKS, Calif., May 30, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla® (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC … Read more
MARLBOROUGH, Mass., May 30, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced today that its Series A 5.50% Mandatory Convertible Preferred Stock (the preferred stock) will automatically convert into shares of the company’s common stock on June 1, 2023. As previously disclosed, holders of record at the close of business on May 15, 2023 … Read more
Graduates are headed to colleges across the country and internationally ATHERTON, Calif., May 30, 2023 /PRNewswire/ — Sacred Heart Preparatory (SHP) graduated 171 students at its 125th commencement ceremony on Friday, May 26, its largest graduating class to date. Graduates from the Class of 2023 will attend 84 different institutions: 72 students will study in … Read more
SEATTLE, May 30, 2023 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) (“CTI”), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has cancelled the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) which was scheduled for June 21, 2023, and has withdrawn the … Read more
SILVER SPRING, Md., May 30, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Friday, the FDA published the FDA Voices: “How FDA’s New Approach to Reviewing Chemicals Added to Food Will Strengthen Food Safety,” by Robert M. Califf, M.D., Commissioner of … Read more
—Quarterly Report on Form 10-Q and Plan of Compliance Have Now Been Submitted to Nasdaq— SAN FRANCISCO, May 30, 2023 /PRNewswire/ — Aurora Technology Acquisition Corp. (NASDAQ: ATAKU, ATAK, ATAKW, ATAKR) (the “Company”) announced that it had previously received written notification (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on May … Read more